TMS for Treatment-Resistant Depression

Treatment-resistant depression (TRD) is not a failure on your part. It's a clinical category describing depression that hasn't responded adequately to at least two antidepressants from different classes, taken at adequate doses for a sufficient duration.

About a third of people with depression don't get adequate relief from oral antidepressants. That's not a small unlucky minority — it's a known limitation of how those medications work, and treatments were developed specifically for this situation.

TMS works through a different mechanism than oral antidepressants. Instead of changing chemical signaling throughout your body, TMS uses focused magnetic pulses to stimulate specific areas of the brain involved in mood regulation — primarily the dorsolateral prefrontal cortex.

It's FDA-cleared, non-invasive, and performed in an outpatient setting. You sit in a chair, stay awake, and can drive yourself home afterward.

• Standard TMS — sessions 5 days/week for ~6 weeks, FDA-cleared
• SAINT accelerated TMS — 5-day protocol with fMRI targeting, FDA-cleared
• SPRAVATO (esketamine) — FDA-approved nasal spray for TRD
• IV ketamine infusions — off-label but widely used
• Ketamine-assisted psychotherapy (KAP)
• Medication management — adjusting or augmenting current medications

A consultation is the place to sort through which treatment may be right for you. We'll review your history, what you've tried, and what your insurance may cover.

Call (954) 827-9793 or schedule a consultation.